Lakefront Biotherapeutics N.V.
LKFT | NASDAQ
$32.28
-$0.05 (-0.15%)
At close: Oct 30, 2026, 4:00 PM ET
$32.31
+$0.03 (+0.09%)
Pre-market:
Nov 2, 2026, 7:57 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Net Income | 320.88M |
Depreciation & Amortization | 55.88M |
Stock-Based Compensation | 24M |
Other Working Capital | -992.01M |
Other Non-Cash Items | 236.49M |
Deferred Income Tax | -18.14M |
Change in Working Capital | -876.57M |
Operating Cash Flow | -257.46M |
Capital Expenditures | -13.86M |
Cash Acquisitions | 19.43M |
Purchase of Investments | -3.47B |
Sales Maturities Of Investments | 3.71B |
Other Investing Acitivies | 40.76M |
Investing Cash Flow | 288.81M |
Debt Repayment | -3.27M |
Common Stock Repurchased | n/a |
Dividend Paid | n/a |
Other Financial Acitivies | n/a |
Financial Cash Flow | -3.27M |
Net Cash Flow | 23.63M |
Free Cash Flow | -271.32M |
Adj. Free Cash Flow | -295.31M |
Maintenance CapEx | n/a |
Growth CapEx | -13.86M |
Owner Earnings | -257.46M |
Add to Watchlist
Select watchlists to add or remove LKFT